IRCT20140525017827N8
Recruiting
未知
Comparison of metabolic, endocrine, and clinical outcomes of treatment with simvastatin and metformin in women with polycystic ovaries
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Polycystic ovarian syndrome.
- Sponsor
- Shiraz University of Medical Sciences
- Enrollment
- 144
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •oligomenorrhea or amenorrhea
- •clinical or laboratory findings of hyperandrogenism
- •existence of polycystic ovaries in ultrasound examination) will be invited to take part in the study
- •Aging 18\-40 years
- •Not suffering from thyroid disorder, Cushing’s syndrome, and hyperprolactinemia
- •Not having kidney disorder, liver disorder, diabetes, and lipid profile disorder
- •Not having the history of cardiovascular diseases and hypertension
- •Not having used ovarian function stimulators or hormonal drugs during the past 3 months
- •Not having used medications affecting insulin or lipid profiles within the past 3 months
- •Not smoking
Exclusion Criteria
- •Getting married
- •Not being willing to continue treatment
- •Presentation of side effects due to consumption of study medications
- •Not following the research protocol
- •Losing weight by 3 kg or more within the past 2 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A clinical trial to compare the clinical, metabolic and hormonal parameters amongst the women who respond to the ovulation induction drug clomiphene citrate and those who do not.Health Condition 1: null- PCOS related infertilityCTRI/2018/03/012640PGIMER Chandigarh164
Completed
Phase 2
Treatment of poly cystic ovarian syndrome.Polycystic ovarian syndrome.Polycystic ovarian syndromeIRCT201405082624N15Vice chancellor for research ,Iran University of Medical Sciences.92
Recruiting
Not Applicable
Does combination of metformin together with myoinositol and D-chiroinositol improve clinical, metabolic and hormonal parameters in women with polycystic ovariesHealth Condition 1: null- Polycystic Ovarian SyndromeCTRI/2018/05/013977AIIMS Rishikesh
Recruiting
Not Applicable
To study the endocrine and metabolic characteristics in different phenotypes of PCOSHealth Condition 1: E282- Polycystic ovarian syndromeCTRI/2023/01/049008ESIPGIMSR Basaidarapur Delhi
Completed
Phase 3
Saxagliptin + Metformin Compared to Saxagliptin or Metformin Monotherapy in PCOS Women With Impaired Glucose HomeostasisPolycystic Ovary SyndromeDisorder of Glucose RegulationNCT02022007Woman's38